123 related articles for article (PubMed ID: 6290058)
1. Combination cis-platinum and etoposide in small-cell lung cancer.
Natale RB; Wittes RE
Cancer Treat Rev; 1982 Jun; 9 Suppl():91-4. PubMed ID: 6290058
[No Abstract] [Full Text] [Related]
2. Treatment of inoperable non-small-cell bronchogenic carcinoma with etoposide and cis-platinum.
Mitrou PS; Fischer M; Weissenfels I; Diehl V; Gropp C; Liesenfeld A; Schmidt M; Berdel WE; Fink U; Graubner M
Cancer Treat Rev; 1982 Jun; 9 Suppl():139-42. PubMed ID: 6889919
[No Abstract] [Full Text] [Related]
3. VP16-213 combined with cis-platinum (CDDP) in the treatment of small cell carcinoma of the lung (SCLC).
Madrigal PA; Manga GP; Palomero I; Gomez RG
Cancer Chemother Pharmacol; 1982; 7(2-3):203-4. PubMed ID: 6282485
[No Abstract] [Full Text] [Related]
4. Etoposide and cis-platinum in non-small-cell bronchogenic carcinoma.
Klastersky J; Longeval E; Nicaise C; Weerts D
Cancer Treat Rev; 1982 Jun; 9 Suppl():133-8. PubMed ID: 6889918
[No Abstract] [Full Text] [Related]
5. Combination chemotherapy of small-cell bronchogenic carcinoma with etoposide (VP-16), ifosfamide and vindesine (VPIV), and with adriamycin, cis-platinum and vincristine (APO).
Havemann K
Cancer Treat Rev; 1982 Jun; 9 Suppl():95-100. PubMed ID: 6290059
[No Abstract] [Full Text] [Related]
6. Cis-dichlorodiammineplatinum (II) and VP 16-213 combination chemotherapy for non-small cell lung cancer.
Goldhirsch A; Joss RA; Cavalli F; Sonntag RW; Brunner KW
Med Pediatr Oncol; 1981; 9(3):205-8. PubMed ID: 6264280
[TBL] [Abstract][Full Text] [Related]
7. cis-Dichlorodiammineplatinum(II) and VP-16-213: an active induction regimen for small cell carcinoma of the lung.
Sierocki JS; Hilaris BS; Hopfan S; Martini N; Barton D; Golbey RB; Wittes RE
Cancer Treat Rep; 1979; 63(9-10):1593-7. PubMed ID: 227598
[TBL] [Abstract][Full Text] [Related]
8. Cyclophosphamide and VP-16-213 with or without cisplatin in squamous cell and small cell lung cancers.
Eagan RT; Frytak S; Nichols WC; Ingle JN; Creagan ET; Kvols LK
Cancer Treat Rep; 1981; 65(5-6):453-8. PubMed ID: 6263477
[TBL] [Abstract][Full Text] [Related]
9. Etoposide as single agent and in combination chemotherapy of bronchogenic carcinoma.
Goldhirsch A; Joss R; Cavalli F; Brunner KW
Cancer Treat Rev; 1982 Jun; 9 Suppl():85-90. PubMed ID: 6290057
[No Abstract] [Full Text] [Related]
10. Cis-dichlorodiammineplatinum (II) (cis-platinum) and etoposide for patients with refractory lymphomas.
von Heyden HW; Scherpe A; Nagel GA
Cancer Treat Rev; 1982 Jun; 9 Suppl():45-52. PubMed ID: 6889921
[No Abstract] [Full Text] [Related]
11. Etoposide after ACO treatment for small-cell bronchogenic carcinoma.
Essers U; Knechten H; Seelis R; Ammon J
Cancer Treat Rev; 1982 Jun; 9 Suppl():111-3. PubMed ID: 6290054
[No Abstract] [Full Text] [Related]
12. Preliminary study of the combination, dianhydrogalactitol, cis-diaminedichloroplatinum (II), and VP-16-213 in patients with advanced cancer.
Creagan ET; Eagan RT; Kvols LK
Oncology; 1981; 38(5):260-1. PubMed ID: 7196561
[TBL] [Abstract][Full Text] [Related]
13. Enhanced radiation reaction following combination chemotherapy for small cell carcinoma of the lung, possibly secondary to VP16-213.
Giever RJ; Heusinkveld RS; Manning MR; Bowden GT
Int J Radiat Oncol Biol Phys; 1982 May; 8(5):921-3. PubMed ID: 6286559
[No Abstract] [Full Text] [Related]
14. VP-16-213 therapy in patients with small-cell carcinoma of the lung after failure on combination chemotherapy.
Tempero M; Kessinger A; Lemon HM
Cancer Clin Trials; 1981; 4(2):155-7. PubMed ID: 6265110
[No Abstract] [Full Text] [Related]
15. Etoposide alone and in combination with cyclophosphamide, adriamycin and cis-platinum in patients with Mo and Mi non-small-cell lung cancer.
Eagan RT
Cancer Treat Rev; 1982 Jun; 9 Suppl():119-31. PubMed ID: 6889917
[No Abstract] [Full Text] [Related]
16. [Treatment of anaplastic carcinoma of the lung with VP 16-213].
Sanz Ortíz J; Saiz García F
Med Clin (Barc); 1982 Oct 16-31; 79(7):322-4. PubMed ID: 6294420
[No Abstract] [Full Text] [Related]
17. Small-cell bronchogenic carcinoma--primary and relapse therapy with etoposide (VP-16), methotrexate and CCNU.
Niederle N; Krischke W; Bremer K; Schmidt CG; Seeber S
Cancer Treat Rev; 1982 Jun; 9 Suppl():101-5. PubMed ID: 6290053
[No Abstract] [Full Text] [Related]
18. [Effects of oral etoposide in small cell carcinoma of the lung].
Miyamoto H; Ito M; Araya Y; Takaoka K; Isobe H; Dosaka H; Kawakami Y; Shimizu T; Onodera S
Gan To Kagaku Ryoho; 1984 Jun; 11(6):1244-7. PubMed ID: 6329103
[TBL] [Abstract][Full Text] [Related]
19. Etoposide and cisplatin salvage chemotherapy for small cell lung cancer.
Lopez JA; Mann J; Grapski RT; Nassif E; Vannicola P; Krikorian JG; Finkel H
Cancer Treat Rep; 1985 Apr; 69(4):369-71. PubMed ID: 2986833
[TBL] [Abstract][Full Text] [Related]
20. High-dose etoposide as single-agent chemotherapy for small cell carcinoma of the lung.
Wolff SN; Johnson DH; Hande KR; Hainsworth JD; Greco FA
Cancer Treat Rep; 1983 Oct; 67(10):957-8. PubMed ID: 6313189
[No Abstract] [Full Text] [Related]
[Next] [New Search]